List of Tables
    Table 1. Sofosbuvir/Ledipasvir Compound Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Sofosbuvir/Ledipasvir Compound Drugs Market Trends
    Table 3. Sofosbuvir/Ledipasvir Compound Drugs Market Drivers
    Table 4. Sofosbuvir/Ledipasvir Compound Drugs Market Challenges
    Table 5. Sofosbuvir/Ledipasvir Compound Drugs Market Restraints
    Table 6. Global Sofosbuvir/Ledipasvir Compound Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Sofosbuvir/Ledipasvir Compound Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Sofosbuvir/Ledipasvir Compound Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Sofosbuvir/Ledipasvir Compound Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Sofosbuvir/Ledipasvir Compound Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Sofosbuvir/Ledipasvir Compound Drugs Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Sofosbuvir/Ledipasvir Compound Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Sofosbuvir/Ledipasvir Compound Drugs Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Sofosbuvir/Ledipasvir Compound Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Sofosbuvir/Ledipasvir Compound Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sofosbuvir/Ledipasvir Compound Drugs as of 2021)
    Table 18. Top Players of Sofosbuvir/Ledipasvir Compound Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Sofosbuvir/Ledipasvir Compound Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Sofosbuvir/Ledipasvir Compound Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Sofosbuvir/Ledipasvir Compound Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Sofosbuvir/Ledipasvir Compound Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Sofosbuvir/Ledipasvir Compound Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Sofosbuvir/Ledipasvir Compound Drugs Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Sofosbuvir/Ledipasvir Compound Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Sofosbuvir/Ledipasvir Compound Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Sofosbuvir/Ledipasvir Compound Drugs Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Sofosbuvir/Ledipasvir Compound Drugs Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Sofosbuvir/Ledipasvir Compound Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Sofosbuvir/Ledipasvir Compound Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Sofosbuvir/Ledipasvir Compound Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Sofosbuvir/Ledipasvir Compound Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Sofosbuvir/Ledipasvir Compound Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Sofosbuvir/Ledipasvir Compound Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Sofosbuvir/Ledipasvir Compound Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Gilead Sciences Corporation Information
    Table 43. Gilead Sciences Description and Business Overview
    Table 44. Gilead Sciences Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Gilead Sciences Sofosbuvir/Ledipasvir Compound Drugs Product
    Table 46. Gilead Sciences Recent Development
    Table 47. Natco Ltd Corporation Information
    Table 48. Natco Ltd Description and Business Overview
    Table 49. Natco Ltd Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Natco Ltd Product
    Table 51. Natco Ltd Recent Development
    Table 52. Zydus Cadila Corporation Information
    Table 53. Zydus Cadila Description and Business Overview
    Table 54. Zydus Cadila Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. Zydus Cadila Product
    Table 56. Zydus Cadila Recent Development
    Table 57. Hetero Drugs Corporation Information
    Table 58. Hetero Drugs Description and Business Overview
    Table 59. Hetero Drugs Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. Hetero Drugs Product
    Table 61. Hetero Drugs Recent Development
    Table 62. Dr Reddy's Laboratories Corporation Information
    Table 63. Dr Reddy's Laboratories Description and Business Overview
    Table 64. Dr Reddy's Laboratories Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. Dr Reddy's Laboratories Product
    Table 66. Dr Reddy's Laboratories Recent Development
    Table 67. Sun Pharmaceutical Industries Corporation Information
    Table 68. Sun Pharmaceutical Industries Description and Business Overview
    Table 69. Sun Pharmaceutical Industries Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. Sun Pharmaceutical Industries Product
    Table 71. Sun Pharmaceutical Industries Recent Development
    Table 72. Cipla Corporation Information
    Table 73. Cipla Description and Business Overview
    Table 74. Cipla Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 75. Cipla Product
    Table 76. Cipla Recent Development
    Table 77. Abbott Corporation Information
    Table 78. Abbott Description and Business Overview
    Table 79. Abbott Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 80. Abbott Product
    Table 81. Abbott Recent Development
    Table 82. Biocon Corporation Information
    Table 83. Biocon Description and Business Overview
    Table 84. Biocon Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 85. Biocon Product
    Table 86. Biocon Recent Development
    Table 87. Torrent Pharmaceuticals Corporation Information
    Table 88. Torrent Pharmaceuticals Description and Business Overview
    Table 89. Torrent Pharmaceuticals Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 90. Torrent Pharmaceuticals Product
    Table 91. Torrent Pharmaceuticals Recent Development
    Table 92. Lupin Ltd Corporation Information
    Table 93. Lupin Ltd Description and Business Overview
    Table 94. Lupin Ltd Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 95. Lupin Ltd Product
    Table 96. Lupin Ltd Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Sofosbuvir/Ledipasvir Compound Drugs Customers List
    Table 100. Sofosbuvir/Ledipasvir Compound Drugs Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Sofosbuvir/Ledipasvir Compound Drugs Product Picture
    Figure 2. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Sofosbuvir/Ledipasvir Compound Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Sofosbuvir/Ledipasvir Compound Drugs Sales 2017-2028 (K Pcs)
    Figure 5. United States Sofosbuvir/Ledipasvir Compound Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Sofosbuvir/Ledipasvir Compound Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Sofosbuvir/Ledipasvir Compound Drugs Sales 2017-2028 (K Pcs)
    Figure 8. United States Sofosbuvir/Ledipasvir Compound Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Sofosbuvir/Ledipasvir Compound Drugs Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Sofosbuvir/Ledipasvir Compound Drugs Report Years Considered
    Figure 11. Product Picture of Bottled Packaging
    Figure 12. Product Picture of Film Coated Packaging
    Figure 13. Global Sofosbuvir/Ledipasvir Compound Drugs Market Share by Type in 2022 & 2028
    Figure 14. Global Sofosbuvir/Ledipasvir Compound Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2017-2028) & (K Pcs)
    Figure 17. Global Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Sofosbuvir/Ledipasvir Compound Drugs Price by Type (2017-2028) & (USD/Pcs)
    Figure 19. United States Sofosbuvir/Ledipasvir Compound Drugs Market Share by Type in 2022 & 2028
    Figure 20. United States Sofosbuvir/Ledipasvir Compound Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2017-2028) & (K Pcs)
    Figure 23. United States Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Sofosbuvir/Ledipasvir Compound Drugs Price by Type (2017-2028) & (USD/Pcs)
    Figure 25. Product Picture of Hepatitis C Virus (HCV) Genotype 1
    Figure 26. Product Picture of Hepatitis C Virus (HCV) Genotype 3
    Figure 27. Product Picture of Hepatitis C Virus (HCV) Genotype 4
    Figure 28. Product Picture of Other
    Figure 29. Global Sofosbuvir/Ledipasvir Compound Drugs Market Share by Application in 2022 & 2028
    Figure 30. Global Sofosbuvir/Ledipasvir Compound Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2017-2028) & (K Pcs)
    Figure 33. Global Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Sofosbuvir/Ledipasvir Compound Drugs Price by Application (2017-2028) & (USD/Pcs)
    Figure 35. United States Sofosbuvir/Ledipasvir Compound Drugs Market Share by Application in 2022 & 2028
    Figure 36. United States Sofosbuvir/Ledipasvir Compound Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2017-2028) & (K Pcs)
    Figure 39. United States Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Sofosbuvir/Ledipasvir Compound Drugs Price by Application (2017-2028) & (USD/Pcs)
    Figure 41. North America Sofosbuvir/Ledipasvir Compound Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 42. North America Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Sofosbuvir/Ledipasvir Compound Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 46. Europe Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 53. Asia-Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Sofosbuvir/Ledipasvir Compound Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 65. Latin America Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Sofosbuvir/Ledipasvir Compound Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 70. Middle East & Africa Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. U.A.E Sofosbuvir/Ledipasvir Compound Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Sofosbuvir/Ledipasvir Compound Drugs Value Chain
    Figure 75. Sofosbuvir/Ledipasvir Compound Drugs Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed